PTAB
IPR2018-01680
Mylan Pharmaceuticals Inc v. Sanofi Aventis Deutschland GmbH
General
Institution04/03/19
FWD05/29/20
Close05/29/20
StatusFinal Written Decision
OutcomeUnpatentable
USPTOIPR2018-01680
Administrative Patent Judges
Judge | Cases | Inst. Rate | FWD Inv. Rate |
|---|---|---|---|
| Bart A Gerstenblith | 500+ | 60% | 77% |
| Hyun J Jung | 600+ | 69% | 87% |
| James A Tartal | 400+ | 64% | 79% |
| James J Mayberry | 400+ | 61% | 84% |
Petitioner
Attorney
Name | Ratings |
|---|---|
L5 A | |
L3 A | |
L1 C | |
-- -- -- | |
-- -- -- |
No Attorneys
Respondent
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 E | |
L3 E | |
L1 D | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
L5 A | |
L5 A | |
L5 A | |
L5 E | |
-- -- -- |
No Attorneys